A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

Bob Belderbos, P Baas, R Berardi, Robin Cornelissen, DA Fennell, JP van Meerbeeck, A Scherpereel, Heleen Vroman, Joachim Aerts, Koen Bezemer, A Rafaelian, M Poncin, I Goktas, Eric Braakman, L van Hove, J Klok, AN Geel, M Vries, Cecile Janssens, X (Xiaoxue) ZhangJ Raskin, S Kohl, A Hufkens, R Claes, MC Willemin, E Wasielewski, M Grammont, S Batista, M Pinturaud, Z Ballatore, A Lucarelli, M Burattini, C Tonnini, F Bianchi, S Pagliaretta, M Hudka, K Lord, L Darlison, B Varadhan, A Hunter

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)280-285
Number of pages6
JournalTranslational Lung Cancer Research
Issue number3
Publication statusPublished - 2019

Cite this